Bond.az White LogoBond.az Black Logo

Knorex Gets NYSE Non-Compliance Notice

KNOREX Ltd. receives NYSE non-compliance notice for delayed filing. The company faces financial challenges.

Mia Lopez
ByMia Lopez- Senior Editor
|
0

SINGAPORE - KNOREX Ltd. (NYSE:KNRX) received a notice from NYSE Regulation on Monday indicating the company is not in compliance with continued listing standards after failing to file its annual report on time.

The company missed the extended May 15, 2026 deadline to file its Form 20-F annual report for the fiscal year ended December 31, 2025. It had previously filed a Form 12b-25 for an extension.

NYSE American will monitor the status for six months through November 15, 2026. If the company fails to file, the exchange may allow trading for an additional six months through May 15, 2027.

The notice has no immediate impact on the listing of the company's class A ordinary shares. They will continue trading on NYSE American during the cure period.

KNOREX is working with accounting, audit and legal professionals to prepare the Form 20-F. However, there is no assurance it will regain compliance.

The company provides AI-driven advertising technology solutions. It operates in the United States, Vietnam, India, Malaysia, and Singapore.

KNOREX faces financial pressures. Its current ratio is just 0.12, indicating liquidity issues. Market capitalization stands at $24.3 million. The company posted a loss of $7.6 million over the last twelve months.

The stock has declined 75% over the past year. It currently trades at $0.78, near its 52-week low of $0.74.

More News
2026-06-01 12:34
|
401

Amber International shareholder to distribute stake pro rata

Amber International's principal shareholder distributes all Class A shares pro rata to existing shareholders; market impact and financial highlights.

0
2026-06-01 12:33
|
213

Palladyne AI Adds Two Retired Generals to Board

Palladyne AI appoints two retired generals to its defense advisory board. Stock up 98% YTD.

0
2026-06-01 12:32
|
381

Cellectar Plans Phase 3 Trial for WM After BTKi

Cellectar Biosciences reports promising Phase 2 results for iopofosine I 131 in Waldenström macroglobulinemia after BTKi therapy, plans Phase 3 trial.

0
2026-06-01 11:33
|
363

essensys Shareholders Approve Re-Registration as Private Company

essensys shareholders approve re-registration as a private company after AIM delisting. All voting shareholders backed the resolution.

0
2026-06-01 08:31
|
890

Causeway Capital Boosts Melrose Stake to 5.12%

Causeway Capital increased its stake in Melrose Industries to 5.12%. The investment firm now holds over 63 million voting rights.

0
2026-06-01 08:03
|
968

Ignitis grupė starts search for new CEO

Ignitis grupė launches CEO search in Lithuania. Learn about requirements and application deadline for the new CEO position.

0
2026-06-01 07:33
|
417

Aquila Renewables: Adviser Withholds Fee Data

Aquila European Renewables says its investment adviser Aquila Capital has not provided complete fee information. The Board is considering legal action.

0
2026-06-01 07:31
|
226

USA Rare Earth Plans €175M France Investment

USA Rare Earth reveals €175 million investment plan in France for metal, alloy and magnet manufacturing, aiming to create over 300 jobs by 2030.

0
2026-06-01 07:30
|
762

Lucid Group Names Silvio Napoli CEO

Lucid Group appoints Silvio Napoli as CEO effective immediately. Stock up 12% in past week but down 38% YTD. Company faces financial challenges.

0
2026-06-01 07:04
|
680

Mkango Reports Q1 2026 Financial Results

Mkango Resources reports Q1 2026 financial results. Details on rare earth projects, recycling operations, and SPAC merger.

0
2026-06-01 07:02
|
274

Greatland secures $500m debt facility, OKs Havieron

Greatland Resources secures $500 million corporate debt facility and board approval for Havieron gold-copper project final investment decision.

0
2026-06-01 07:00
|
543

Calnex director buys shares at 69.9p

Calnex Solutions non-executive director Graeme Bissett buys 28,610 shares at 69.9p each on the London Stock Exchange.

0
...
Knorex Gets NYSE Non-Compliance Notice | Bond.az